Avalo Therapeutics, Inc. (AVTX) Insider Ownership

Historic Insider Ownership Trends

As of May 30, 2026, the three largest insider holders of AVTX are Garry Arthur Neil (Chief Executive Officer, 90.11K shares), Christopher Ryan Sullivan (Chief Financial Officer, 17.34K shares), Samantha Truex (Director, 6.33K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Gilla Kaplan - 6,333 0 31 Mar, 2026
June Sherie Almenoff - 3,167 0 01 Apr, 2025
Garry Arthur Neil Chief Executive Officer 90,114 0 31 Mar, 2026
Capital, Llc Armistice - 0 3,048 28 Jun, 2023
Paul Varki Chief Legal Officer 3,634 0 12 Dec, 2025
James Archie Jr Harrell Chief Commercial Officer 153 0 14 Dec, 2021
H Jeffrey Wilkins Chief Medical Officer 139 0 14 Dec, 2021
Mitchell Chan - 6,333 0 31 Mar, 2026
Christopher Ryan Sullivan Chief Financial Officer 17,338 0 03 Apr, 2026
Schond L. Greenway Cfo 16 0 14 Dec, 2021
Aaron Kantoff - 6,333 0 31 Mar, 2026
Mittie Doyle Chief Medical Officer 3,622 0 08 Apr, 2026
Capital Management Ltd. Caissa - 0 5,772 30 May, 2023
Jonathan Goldman - 3,166 0 31 Mar, 2026
Samantha Truex - 6,333 0 31 Mar, 2026
Jennifer Riley Chief Strategy Officer 2,655 0 12 Dec, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
06 Apr, 2026 Mittie Doyle Common Stock A 3,970 $12.65 7,592 D M
06 Apr, 2026 Mittie Doyle Common Stock D 3,970 $18.01 3,622 D S
06 Apr, 2026 Mittie Doyle Stock Option (Right to Buy) D 3,970 $0.00 210,530 D M
01 Apr, 2026 Christopher Ryan Sullivan Common Stock D 500 $15.86 32,797 D S
01 Apr, 2026 Christopher Ryan Sullivan Common Stock D 500 $15.86 32,797 D S
01 Apr, 2026 Mittie Doyle Common Stock A 679 $8.04 4,301 D M
01 Apr, 2026 Christopher Ryan Sullivan Common Stock D 500 $15.86 32,797 D S
01 Apr, 2026 Christopher Ryan Sullivan Common Stock D 7,479 $16.83 25,318 D S
01 Apr, 2026 Christopher Ryan Sullivan Common Stock D 7,479 $16.83 25,318 D S
01 Apr, 2026 Mittie Doyle Common Stock D 679 $16.00 3,622 D S
01 Apr, 2026 Christopher Ryan Sullivan Common Stock D 7,479 $16.83 25,318 D S
02 Apr, 2026 Christopher Ryan Sullivan Common Stock D 6,200 $17.02 19,118 D S
02 Apr, 2026 Christopher Ryan Sullivan Common Stock D 6,200 $17.02 19,118 D S
02 Apr, 2026 Christopher Ryan Sullivan Common Stock D 6,200 $17.02 19,118 D S
01 Apr, 2026 Mittie Doyle Stock Option (Right to Buy) D 679 $0.00 148,329 D M
02 Apr, 2026 Christopher Ryan Sullivan Common Stock D 1,780 $17.57 17,338 D S
02 Apr, 2026 Christopher Ryan Sullivan Common Stock D 1,780 $17.57 17,338 D S
02 Apr, 2026 Christopher Ryan Sullivan Common Stock D 1,780 $17.57 17,338 D S
31 Mar, 2026 Rita Jain Stock Option (Right to Buy) A 1,339 $12.13 1,339 D A
31 Mar, 2026 Kevin Robert Lind Stock Option (Right to Buy) A 1,370 $12.13 1,370 D A